ISM5939 | ISM5939 : Inhibitor of ENPP1
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
ENPP1
  • IC50:0.45 nM
  • IC50:9.28 nM
  • Kd:0.38 nM
  • EC50:0.1 nM
Inhibitor
up to 100 nM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
Specificity of ISM5939 for ENPP1: inhibitory effects on ENPP2 and ENPP3 were assessed enzymatically ...
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Broader selectivity of ISM5939 was assessed on the ICESTP™ SafetyOne44 panel, which encompasses a co ...

Potency
Cellular
In Vitro

ENPP1

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1038/s41467-025-59874-0

In Vivo Validations

Mouse
Dose: 1 mg/kg IV, 5 mg/kg PO
Route of delivery: Intravenous, Oral
Systemic clearance: 14 mL/min/kg IV
Bioavailability: 32%
Volume of Distribution at Steady-State: 0.53 L/Kg

DOI Reference: 10.1038/s41467-025-59874-0

Rat
Dose: 1 mg/kg IV, 5 mg/kg PO
Route of delivery: Intravenous, Oral
Systemic clearance: 14 mL/min/kg IV
Bioavailability: 49%
Volume of Distribution at Steady-State: 1.1 L/Kg IV

DOI Reference: 10.1038/s41467-025-59874-0

Monkey (Cynomolgus)
Dose: 1 mg/kg IV, 5 mg/kg PO
Route of delivery: Intravenous, Oral
Systemic clearance: 2.0 mL/min/kg IV
Bioavailability: 45%
Volume of Distribution at Steady-State: 0.63 L/Kg IV

DOI Reference: 10.1038/s41467-025-59874-0

Chemical Information

Molecular Formula C20H18FN5O3S
SMILEs COc1ncc2nc(C)n(Cc3ncc(S(N)(=O)=O)cc3F)c2c1-c1ccccc1
InChI InChI=1S/C20H18FN5O3S/c1-12-25-16-10-24-20(29-2)18(13-6-4-3-5-7-13)19(16)26(12)11-17-15(21)8-14(9-23-17)30(22,27)28/h3-10H,11H2,1-2H3,(H2,22,27,28)
Molecular weight 427.11 Da
AlogP 2.6451200000000012
HBond acceptors 8
HBond donors 2
Atoms 48

References

Cross References

Expert Reviews


No SERP comments found for ISM5939

Probe ISM5939 is in the process of SERP review.

Please continue to check back for new reviews and commentary.